BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Arch Dermatol. 2007;143:45-50. [PMID: 17224541 DOI: 10.1001/archderm.143.1.45] [Cited by in Crossref: 56] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hsi AC, Lee SJ, Rosman IS, Carson KR, Kelley A, Viele V, Pang X, Musiek A, Schaffer A. Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: Diagnostic implications. Journal of the American Academy of Dermatology 2015;72:159-67. [DOI: 10.1016/j.jaad.2014.09.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
2 Olsen EA, Hodak E, Anderson T, Carter JB, Henderson M, Cooper K, Lim HW. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium. J Am Acad Dermatol 2016;74:27-58. [PMID: 26547257 DOI: 10.1016/j.jaad.2015.09.033] [Cited by in Crossref: 76] [Cited by in F6Publishing: 45] [Article Influence: 12.7] [Reference Citation Analysis]
3 Amber KT, Bloom R, Nouri K. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype. Am J Clin Dermatol. 2016;17:71-77. [PMID: 26386881 DOI: 10.1007/s40257-015-0155-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 4.4] [Reference Citation Analysis]
4 Pai RK, Mullins FM, Kim YH, Kong CS. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies. Cancer 2008;114:323-32. [PMID: 18798522 DOI: 10.1002/cncr.23793] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mazzeo E, Rubino L, Buglione M, Antognoni P, Magrini SM, Bertoni F, Parmiggiani M, Barbieri P, Bertoni F. The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications. Rep Pract Oncol Radiother 2014;19:77-91. [PMID: 24936325 DOI: 10.1016/j.rpor.2013.07.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Goyal A, O'Leary D, Goyal K, Rubin N, Bohjanen K, Hordinsky M, Chen ST, Pongas G, Duncan LM, Lazaryan A. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis. J Am Acad Dermatol 2020;83:404-11. [PMID: 31374302 DOI: 10.1016/j.jaad.2019.07.075] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
7 . Mycosis fungoides. Skin Lymphoma. Wiley; 2020. pp. 23-112. [DOI: 10.1002/9781119485933.ch3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lindahl LM, Fenger-Grøn M, Iversen L. Subsequent cancers, mortality, and causes of death in patients with mycosis fungoides and parapsoriasis: a Danish nationwide, population-based cohort study. J Am Acad Dermatol. 2014;71:529-535. [PMID: 24836079 DOI: 10.1016/j.jaad.2014.03.044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
9 Ferenczi K, Makkar HS. Cutaneous lymphoma: Kids are not just little people. Clinics in Dermatology 2016;34:749-59. [DOI: 10.1016/j.clindermatol.2016.07.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
10 Goyal A, O'Leary D, Goyal K, Patel K, Pearson D, Janakiram M. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer: A systematic review and meta-analysis. J Am Acad Dermatol 2020:S0190-9622(20)32444-0. [PMID: 32822803 DOI: 10.1016/j.jaad.2020.06.1033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Pirani M, Marcheselli R, Marcheselli L, Bari A, Federico M, Sacchi S. Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis. Ann Oncol 2011;22:1845-58. [PMID: 21310758 DOI: 10.1093/annonc/mdq697] [Cited by in Crossref: 52] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
12 Eder J, Kern A, Moser J, Kitzwögerer M, Sedivy R, Trautinger F. Frequency of primary cutaneous lymphoma variants in Austria: retrospective data from a dermatology referral centre between 2006 and 2013. J Eur Acad Dermatol Venereol 2015;29:1517-23. [PMID: 25600184 DOI: 10.1111/jdv.12907] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Chihara D, Dores G, Flowers C, Morton LM. The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma. Blood 2021:blood. [PMID: 33822002 DOI: 10.1182/blood.2020010497] [Reference Citation Analysis]
14 Kim YJ, Shin HJ, Won CH, Chang SE, Lee MW, Choi JH, Lee WJ. The Incidence of Other Primary Cancers in Patients with Cutaneous Lymphoma. Ann Dermatol 2018;30:335-41. [PMID: 29853749 DOI: 10.5021/ad.2018.30.3.335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
15 Ramachandran V, Park KE, Torres-Cabala CA, Duvic M. Second primary malignancies in subcutaneous panniculitis-like T-cell lymphoma: a national database study. Clin Exp Dermatol 2020;45:755-7. [PMID: 32359183 DOI: 10.1111/ced.14262] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Stephen S, Kim EJ, Introcaso CE, Richardson SK, Rook AH. Cutaneous T-Cell Lymphoma. In: Gaspari AA, Tyring SK, Kaplan DH, editors. Clinical and Basic Immunodermatology. Cham: Springer International Publishing; 2017. pp. 715-40. [DOI: 10.1007/978-3-319-29785-9_41] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Brownell I, Etzel CJ, Yang DJ, Taylor SH, Duvic M. Increased malignancy risk in the cutaneous T-cell lymphoma patient population. Clin Lymphoma Myeloma. 2008;8:100-105. [PMID: 18501103 DOI: 10.3816/clm.2008.n.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). Journal of the American Academy of Dermatology 2014;70:205.e1-205.e16. [DOI: 10.1016/j.jaad.2013.07.049] [Cited by in Crossref: 162] [Cited by in F6Publishing: 106] [Article Influence: 23.1] [Reference Citation Analysis]
19 Kaul S, Belzberg M, Hughes JM, Mahadevan V, Khanna R, Bakhshi PR, Hong MS, Williams KA, Grossberg AL, Kwatra SG, Sweren RJ. Comorbidities in Mycosis Fungoides and Racial Differences in Co-Existent Lymphomatoid Papulosis: A Cross-Sectional Study of 580 Patients in an Urban Tertiary Care Center. Medicines (Basel) 2019;7:E1. [PMID: 31888015 DOI: 10.3390/medicines7010001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Wollina U. Cutaneous T cell lymphoma: update on treatment: Cutaneous T cell lymphoma: treatment update. International Journal of Dermatology 2012;51:1019-36. [DOI: 10.1111/j.1365-4632.2011.05337.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
21 Kamel JG, Amber KT. Second primary cutaneous T-cell lymphoma in patients with non-Hodgkin lymphoma: a chicken-or-the-egg issue. Int J Dermatol 2018;57:113. [PMID: 29047113 DOI: 10.1111/ijd.13803] [Reference Citation Analysis]
22 Lee J, Richardson SK, Melhem ER, Rook AH, Kim EJ. Progressive multifocal leukoencephalopathy from JC virus in a patient with advanced mycosis fungoides. J Am Acad Dermatol 2007;57:893-5. [PMID: 17761357 DOI: 10.1016/j.jaad.2007.06.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
23 Carton de Tournai D, Deschamps L, Laly P, Zeboulon C, Bouaziz J, Ram-wolff C, Doumecq-lacoste J, Ortonne N, Rivet J, Battistella M, Bagot M. Mycosis fongoïde chalazodermique associé à un séminome testiculaire métastatique. Annales de Dermatologie et de Vénéréologie 2017;144:446-9. [DOI: 10.1016/j.annder.2017.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Wang SS, Vose JM. Epidemiology and Prognosis of T-Cell Lymphoma. In: Foss F, editor. T-Cell Lymphomas. Totowa: Humana Press; 2013. pp. 25-39. [DOI: 10.1007/978-1-62703-170-7_2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]